September 03, 2019

Lauren Crowder was recently accepted into two AABB committees for the 2019-2020 year, beginning October 1, 2019.

August 26, 2019

TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations.

August 26, 2019

Case reports and small prospective trials suggest that administering targeted therapies to patients with advanced cancer and an identified genomic target may be associated with clinical benefit.

August 20, 2019

Objectives: To evaluate the impact of the Executive Training on Navigation and Survivorship (Executive Training) online training course, designed by the George Washington University Cancer Center, on nurses and other healthcare professionals.